Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hann

Showing results (201-210 of 239) with videos related to

Pageof 24
Sort By:
Journal of Biomolecular Screening|September 5, 2015
Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell PermeabilityLaurie J Gordon, Morven Allen, Per Artursson, et al.
British Journal of Haematology|March 5, 2003
Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemiaEmma C Morris, Georgina Harrison, Clifford C Bailey, et al.
Journal of Pain and Symptom Management|April 20, 2001
Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancerE L Smith, D M Hann, T A Ahles, et al.
Bone Marrow Transplantation|July 1, 1990
Autograft to eliminate minimal residual disease in AML in first remission--update on the Glasgow experienceA K Burnett, K Pendry, P M Rawlinson, et al.
Leukemia|November 24, 2005
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trialsB E S Gibson, K Wheatley, I M Hann, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptorH Ulrich, J E Ippolito, O R Pagán, et al.
Journal of Medicinal Chemistry|October 15, 1993
A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: structural and modeling studiesA Wonacott, R Cooke, F R Hayes, et al.
Leukemia|February 24, 2001
Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working PartyO B Eden, G Harrison, S Richards, et al.
Leukemia|May 3, 2002
Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working partyJ M Chessells, C J Harrison, H Kempski, et al.
Pageof 24

Showing results (201-210 of 239) with videos related to

Sort By:
Pageof 24
Journal of Biomolecular Screening|September 5, 2015
Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell PermeabilityLaurie J Gordon, Morven Allen, Per Artursson, et al.
British Journal of Haematology|March 5, 2003
Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemiaEmma C Morris, Georgina Harrison, Clifford C Bailey, et al.
Journal of Pain and Symptom Management|April 20, 2001
Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancerE L Smith, D M Hann, T A Ahles, et al.
Bone Marrow Transplantation|July 1, 1990
Autograft to eliminate minimal residual disease in AML in first remission--update on the Glasgow experienceA K Burnett, K Pendry, P M Rawlinson, et al.
Leukemia|November 24, 2005
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trialsB E S Gibson, K Wheatley, I M Hann, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptorH Ulrich, J E Ippolito, O R Pagán, et al.
Journal of Medicinal Chemistry|October 15, 1993
A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: structural and modeling studiesA Wonacott, R Cooke, F R Hayes, et al.
Leukemia|February 24, 2001
Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working PartyO B Eden, G Harrison, S Richards, et al.
Leukemia|May 3, 2002
Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working partyJ M Chessells, C J Harrison, H Kempski, et al.
Pageof 24